Gene · 690
Papers2,843
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,843
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NOTCH Signaling in Osteosarcoma. | Curr Issues Mol Biol | 2023 | 36975516 | PubTator, text mining | PubMed |
| Effect of Bifidobacterium on osteoclasts: TNF-α/NF-κB inflammatory signal pathway-mediated mechanism. | Front Endocrinol (Lausanne) | 2023 | 36967748 | PubTator, text mining | PubMed |
| The role of microenvironment in the initiation and evolution of B-cell precursor acute lymphoblastic leukemia. | Front Oncol | 2023 | 36959797 | PubTator, text mining | PubMed |
| Clinical value of RANKL, OPG, IL-6 and sclerostin as biomarkers for fibrous dysplasia/McCune-Albright syndrome. | Bone | 2023 | 36958543 | PubTator, text mining | PubMed |
| Prevalence and pattern of third molars impaction: A retrospective radiographic study. | J Adv Pharm Technol Res | 2023 | 36950463 | PubTator, text mining | PubMed |
| Author Correction: A 92 protein inflammation panel performed on sonicate fluid differentiates periprosthetic joint infection from non-infectious causes of arthroplasty failure. | Sci Rep | 2023 | 36949160 | PubTator, text mining | PubMed |
| A plasma 3-marker microRNA biosignature distinguishes spinal tuberculosis from other spinal destructive diseases and pulmonary tuberculosis. | Front Cell Infect Microbiol | 2023 | 36926516 | PubTator, text mining | PubMed |
| The role and regulation mechanism of Chinese traditional fitness exercises on the bone and cartilage tissue in patients with osteoporosis: A narrative review. | Front Physiol | 2023 | 36926189 | PubTator, text mining | PubMed |
| Mandibular Block Graft for Localised Ridge Augmentation Followed by Delayed Implant Placement: A Case Report. | Cureus | 2023 | 36925988 | PubTator, text mining | PubMed |
| N6-Methyladenosine Modification of ANLN Enhances Hepatocellular Carcinoma Bone Metastasis. | Int J Biol Sci | 2023 | 36923927 | PubTator, text mining | PubMed |
| Resolvin D1 improves allograft osteointegration and directly enhances osteoblasts differentiation. | Front Immunol | 2023 | 36923414 | PubTator, text mining | PubMed |
| Case report: Revascularization failure in NF1-related moyamoya syndrome after selumetinib: A possible pathophysiological correlation? | Front Pediatr | 2023 | 36923276 | PubTator, text mining | PubMed |
| Recombinant Irisin Protects Against Alveolar Bone Destruction During Orthodontic Tooth Movement. | Inflammation | 2023 | 36918436 | PubTator, text mining | PubMed |
| High levels of LIGHT/TNFSF14 in patients with Prader-Willi syndrome. | J Endocrinol Invest | 2023 | 36917420 | PubTator, text mining | PubMed |
| FDC-SP as a diagnostic and prognostic biomarker and modulates immune infiltrates in renal cell carcinoma. | BMC Bioinformatics | 2023 | 36899339 | PubTator, text mining | PubMed |
| Editorial: Reviews in rheumatology. | Front Med (Lausanne) | 2023 | 36895720 | PubTator, text mining | PubMed |
| Relationship between soluble neuropilin-1 in the gingival crevicular fluid of early pregnant women and different severities of periodontitis: A cross-sectional study. | J Oral Biol Craniofac Res | 2023 | 36891285 | PubTator, text mining | PubMed |
| Bone Mineral Content Distribution in Response to Long-term Training of Elite Rowers. | In Vivo | 2023 | 36881058 | PubTator, text mining | PubMed |
Combination model of neutrophil to high-density lipoprotein ratio and system inflammation response index is more valuable for predicting peripheral arterial disease in type 2 diabetic patients: A cross-sectional study. | Front Endocrinol (Lausanne) | 2023 | 36875480 | PubTator, text mining | PubMed |
| Remnant cholesterol is independently asssociated with an increased risk of peripheral artery disease in type 2 diabetic patients. | Front Endocrinol (Lausanne) | 2023 | 36875452 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/690/papers?page=34